Key Details
Price
$72.85Last Dividend
$0.50TTM Dividend Yield
2.04%PE Ratio
34.94Annual ROE
15.63%Beta
0.21Events Calendar
Next earnings date:
Feb 6, 2025Recent quarterly earnings:
Nov 12, 2024Recent annual earnings:
Feb 6, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
Aug 9, 2024Next split:
N/ARecent split:
Jul 27, 2015Analyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Events
Dividend per share
Dividend yield
Other
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
NEW YORK, NY / ACCESS Newswire / February 6, 2025 / If you experienced a loss from your investment in AstraZeneca PLC (NASDAQ:AZN) and are interested in finding out about possible recovery options under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=127649&wire=1 or reach out to Joseph E. Levi, Esq.
NEW YORK, Feb. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a worldwide law firm focused on investor rights, is reminding buyers of AstraZeneca PLC (NASDAQ: AZN) securities from February 23, 2022, to December 17, 2024, that the deadline to become the lead plaintiff in the securities class action is February 21, 2025.
NEW YORK, NY / ACCESS Newswire / February 6, 2025 / If you experienced a loss from your investment in AstraZeneca PLC (NASDAQ:AZN) and are interested in finding out about possible recovery options under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=127614&wire=1 or reach out to Joseph E. Levi, Esq.
NEW YORK, NY / ACCESS Newswire / February 6, 2025 / If you experienced a loss from your investment in AstraZeneca PLC (NASDAQ:AZN) and are interested in possible recovery under federal securities laws, please click the link below for further details: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=127490&wire=1 or reach out to Joseph E. Levi, Esq.
NEW YORK, Feb. 6, 2025 /PRNewswire/ -- The Gross Law Firm has an announcement for AstraZeneca PLC (NASDAQ: AZN) shareholders. Those who bought AZN shares during the specified time are invited to reach out to the firm about the chance to be appointed as lead plaintiff.
AstraZeneca PLC (LSE:AZN) may have to pay a fine of as much as £4.5 million due to a Chinese investigation into the possible illegal import of cancer medications Imfinzi and Imjudo. The Shenzhen City Customs believes there are $0.9 million in unpaid import taxes, and AstraZeneca thinks the fines could be between one and five times that amount.
AstraZeneca PLC (LSE:AZN) saw its shares rise by 3.5% in early trading, increasing its market value by £6 billion, thanks to impressive annual profits from its cancer, lung, and immunology drugs. In 2024, the company's revenue increased by 21% to $54.1 billion (£43 billion), and its pre-tax profit rose by 38% to $8.7 billion when adjusted for constant currency.
On Thursday, AstraZeneca predicted that its sales for 2025 would exceed what analysts had expected, following a strong performance in the fourth quarter. This success was mainly due to high demand for its cancer and heart disease medications.
If you experienced a loss from your investment in AstraZeneca PLC (NASDAQ:AZN) and are interested in possible recovery under federal securities laws, you can find more details by following the link below: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=127635&wire=1 or reach out to Joseph E. Levi, Esq.
AstraZeneca has shared mixed results for the fourth quarter. The company's stock rose in pre-market trading after it reassured investors that the effects of the investigations in China are not significant.
FAQ
- What is the ticker symbol for AstraZeneca?
- Does AstraZeneca pay dividends?
- What sector is AstraZeneca in?
- What industry is AstraZeneca in?
- What country is AstraZeneca based in?
- When did AstraZeneca go public?
- Is AstraZeneca in the S&P 500?
- Is AstraZeneca in the NASDAQ 100?
- Is AstraZeneca in the Dow Jones?
- When was AstraZeneca's last earnings report?
- When does AstraZeneca report earnings?
- Should I buy AstraZeneca stock now?